The road to validating preimplantation genetic testing for aneuploidy; are we there yet?

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
The road to validating preimplantation genetic testing for aneuploidy; are we there yet?

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

The road to validating preimplantation genetic testing for aneuploidy; are we there yet?

As preimplantation genetic testing for aneuploidy (PGT-A) becomes increasingly used, the need to understand the true value of this test increases. The rapid proliferation of this technology raises some obvious questions. Does PGT-A result in the discard of embryos with significant reproductive poten…

VOLUME 115, ISSUE 3, P585-586, MARCH 01, 2021

Authors:

K.C. Humm, M.D., David Frankfurter, M.D.

Abstract:

Reflections on "A multicenter, prospective, blinded nonselection study evaluation the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing–based preimplantation genetic testing for aneuploidy assay and impact of biopsy" by Tiegs et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content